Patents Assigned to KIMMERLING HOLDINGS GROUP, LLC
  • Synthesis of antimicrobial silsesquioxane-silica hybrids
    Patent number: 11679064
    Abstract: One-pot synthetic methods are disclosed for synthesizing curable, antimicrobial silsesquioxane-silica hybrids by hydrolytically co-condensing a tetraalkoxysilane with two different trialkoxysilanes. Particles are also disclosed that are substantially spherical and have an ordered lamellar internal structure. In addition, polymers prepared front the curable, antimicrobial silsesquioxane-silica hybrids and co-monomers are disclosed.
    Type: Grant
    Filed: April 26, 2021
    Date of Patent: June 20, 2023
    Assignee: KIMMERLING HOLDINGS GROUP, LLC
    Inventors: Franklin R. Tay, Shi-qiang Gong, Kirk Kimmerling
  • Synthesis of antimicrobial silsesquioxane-silica hybrids
    Patent number: 10995181
    Abstract: One-pot synthetic methods are disclosed for synthesizing curable, antimicrobial silsesquioxane-silica hybrids by hydrolytically co-condensing a tetraalkoxysilane with two different trialkoxysilanes. Particles are also disclosed that are substantially spherical and have an ordered lamellar internal structure. In addition, polymers prepared from the curable, antimicrobial silsesquioxane-silica hybrids and co-monomers are disclosed.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: May 4, 2021
    Assignee: KIMMERLING HOLDINGS GROUP, LLC
    Inventors: Franklin R. Tay, Shi-Qiang Gong, Kirk Kimmerling
  • Method of decreasing dermal absorption using composition comprising siloxane polymer
    Patent number: 10780169
    Abstract: Methods of reducing dermal penetration of at least one active ingredient in a topically applied product using compositions comprising siloxane polymers are disclosed. In some aspects, the active ingredient is an antimicrobial agent, especially benzalkonium chloride, 3-(trimethoxysilyl) propyldimethyloctadecyl ammonium chloride, and combinations thereof.
    Type: Grant
    Filed: April 2, 2020
    Date of Patent: September 22, 2020
    Assignee: Kimmerling Holdings Group, LLC
    Inventor: Kirk A. Kimmerling
  • Synthesis of antimicrobial silsesquioxane-silica hybrids
    Patent number: 10189954
    Abstract: One-pot synthetic methods are disclosed for synthesizing curable, antimicrobial silsesquioxane-silica hybrids by hydrolytically co-condensing a tetraalkoxysilane with two different trialkoxysilanes. Particles are also disclosed that are substantially spherical and have an ordered lamellar internal structure. In addition, polymers prepared from the curable, antimicrobial silsesquioxane-silica hybrids and co-monomers are disclosed.
    Type: Grant
    Filed: August 15, 2014
    Date of Patent: January 29, 2019
    Assignee: Kimmerling Holdings Group, LLC
    Inventors: Franklin R. Tay, Shi-qiang Gong, Kirk Kimmerling
  • Two- and three-component siloxane and related compounds and compositions
    Patent number: 10159630
    Abstract: Compositions are disclosed that comprise at least one compound of formula IV: wherein the variable are as defined in the specification. The compositions are antimicrobial and optionally curable, and useful, inter alia, in dental, medical, and industrial applications for reinforcement and/or adhering two surfaces together.
    Type: Grant
    Filed: March 10, 2016
    Date of Patent: December 25, 2018
    Assignee: Kimmerling Holdings Group, LLC
    Inventors: John D. Blizzard, Kirk Kimmerling, Joseph P. Rapp
  • Two- and three-component siloxanes and related compounds and compositions
    Patent number: 9314407
    Abstract: Compositions are disclosed that comprise at least one compound of formula IV: wherein the variable are as defined in the specification. The compositions are antimicrobial and optionally curable, and useful, inter alia, in dental, medical, and industrial applications for reinforcement and/or adhering two surfaces together.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: April 19, 2016
    Assignee: KIMMERLING HOLDINGS GROUP, LLC
    Inventors: John D. Blizzard, Kirk Kimmerling, Joseph P. Rapp